OpenVSafe by OpenVAERS
Search V-safe

ZCC-15546-21356

3 vaccinations 18 coded responses 35 check-ins 18 free-text entries 4 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
301 / GA
Registered
2021-04-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-07
    Registered in v-safe
  2. 2021-04-07
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-07
    Survey response — day 0, dose 1
    MedDRA: Lip swelling, Swelling face — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Facial and lip swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  5. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-04-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hypoacusis, Visual impairment — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Changes in vision and hearing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hypoacusis — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Hearing issues
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-13
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-04-14
    Survey response — day 7, dose 1
    MedDRA: Cough, Hearing disability, Heart rate increased, Pollakiuria, Visual impairment — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Cough, excessive urination, hearing and vision issues, rapid heartbeat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-21
    Survey response — day 14, dose 1
    MedDRA: Bronchitis, Ear pain, Fatigue, Rash — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Ear pain, bronchitis, fatigue, rash
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-21
    Report sent to call center — day 14, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-04-28
    Dose 2 — Pfizer-BioNTech
  15. 2021-04-28
    Survey response — day 0, dose 2
    MedDRA: Ear pain — Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Ear pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Urinary incontinence — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Urinary incontinence
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Ear pain — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Ear pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-05-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Ear pain, Hypoacusis — Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Ear pain and trouble hearing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough, Ear pain, Hot flush, Temperature regulation disorder — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Hot flashes, unable to regulate body temp, cough, ear pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Cough, Ear pain — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Coughing, ear pain, chest pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-05
    Survey response — day 7, dose 2
    MedDRA: Agitation, Ear pain, Hot flush — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Unable to regulate body temperature, hot flashes, ear pain, agitation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-05-12
    Survey response — day 14, dose 2
    MedDRA: Cough, Dyspnoea, Fatigue, Gastrointestinal disorder — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Coughing, difficulty breathing, fatigue, gastrointestinal issues
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-12
    Report sent to call center — day 14, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-05-19
    Survey response — day 21, dose 2
    MedDRA: Cough, Gastrointestinal disorder, Hyperacusis, Visual impairment — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Cough, vision impairment, hearing trouble, gastrointestinal issues
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-19
    Report sent to call center — day 21, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-05-28
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  27. 2021-06-04
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  28. 2021-06-12
    Survey response — day 42, dose 2
    MedDRA: Arthralgia, Fatigue, Temperature regulation disorder, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Exhaustion, inability to regulate body temperature, joint pain, extreme fatigue, vision issues
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-07-28
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  30. 2021-10-29
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  31. 2021-11-05
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  32. 2021-11-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Redness, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  33. 2021-11-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  34. 2021-11-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  35. 2021-11-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  36. 2021-11-14
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  37. 2021-11-19
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  38. 2021-11-26
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  39. 2021-12-03
    Survey response — day 28, dose 3
    MedDRA: Arthralgia, Headache, Pain in extremity — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Joint and leg pain. Headaches.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2021-12-12
    Survey response — day 35, dose 3
    MedDRA: Arthralgia, Pain in extremity — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Joint and limb pain
    MedDRA releases: 2024-11 · check-in free text available
  41. 2021-12-19
    Survey response — day 42, dose 3
    MedDRA: Arthralgia, Pain in extremity — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Joint and limb pain
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-02-04
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  43. 2022-04-07
    Call successful
    Participant prefers to complete VAERS report online
  44. 2022-11-05
    Health check-in — 12 months, dose 3
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-07Pfizer-BioNTech
22021-04-28Pfizer-BioNTech
32021-11-05Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2021-04-13 Successful Participant prefers to complete VAERS report online
2021-04-21 Successful Participant prefers to complete VAERS report online
2021-05-12 Successful Participant prefers to complete VAERS report online
2021-05-19 Successful
2022-04-07
 Participant prefers to complete VAERS report online

Free text

Release 7 — day 0, dose 1

2021-04-07

Systemic reaction (other): Facial and lip swelling

Release 7 — days 1–6 daily, dose 1

2021-04-12

Systemic reaction (other): Changes in vision and hearing

2021-04-13

Systemic reaction (other): Hearing issues

Release 7 — day 7, dose 1

2021-04-14

Systemic reaction (other): Cough, excessive urination, hearing and vision issues, rapid heartbeat

Release 7 — day 14, dose 1

2021-04-21

Symptoms: Ear pain, bronchitis, fatigue, rash

Release 8 — day 0, dose 2

2021-04-28

Systemic reaction (other): Ear pain

Release 8 — days 1–6 daily, dose 2

2021-04-29

Systemic reaction (other): Urinary incontinence

2021-04-30

Systemic reaction (other): Ear pain

2021-05-01

Systemic reaction (other): Ear pain and trouble hearing

2021-05-03

Systemic reaction (other): Hot flashes, unable to regulate body temp, cough, ear pain

2021-05-04

Systemic reaction (other): Coughing, ear pain, chest pain

Release 8 — day 7, dose 2

2021-05-05

Systemic reaction (other): Unable to regulate body temperature, hot flashes, ear pain, agitation

Release 8 — day 14, dose 2

2021-05-12

Symptoms: Coughing, difficulty breathing, fatigue, gastrointestinal issues

Release 8 — day 21, dose 2

2021-05-19

Symptoms: Cough, vision impairment, hearing trouble, gastrointestinal issues

Release 9 — day 42, dose 2

2021-06-12

Symptoms: Exhaustion, inability to regulate body temperature, joint pain, extreme fatigue, vision issues

Release 10 — day 28, dose 3

2021-12-03

Symptoms: Joint and leg pain. Headaches.

Release 10 — day 35, dose 3

2021-12-12

Symptoms: Joint and limb pain

Release 10 — day 42, dose 3

2021-12-19

Symptoms: Joint and limb pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDBronchitis ✓ ✓ ✓
SDCough ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDEar pain ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDGastrointestinal disorder ✓ ✓ ✓
SDHeadache · · ✓
SDHyperacusis ✓ ✓ ✓
SDPain in extremity · · ✓
SDRash ✓ ✓ ✓
SDTemperature regulation disorder ✓ ✓ ✓
SDVisual impairment ✓ ✓ ✓
SROAgitation ✓ ✓ ✓
SROChest pain ✓ ✓ ✓
SROCough ✓ ✓ ✓
SROEar pain ✓ ✓ ✓
SROHearing disability ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓
SROHot flush ✓ ✓ ✓
SROHypoacusis ✓ ✓ ✓
SROLip swelling ✓ ✓ ✓
SROPollakiuria ✓ ✓ ✓
SROSwelling face ✓ ✓ ✓
SROTemperature regulation disorder ✓ ✓ ✓
SROUrinary incontinence ✓ ✓ ✓
SROVisual impairment ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…